Investigación e innovación al servicio de la sociedad
Parc Taulí participates in the Smart City Expo World Congress
1024 559 Anna Ullastres

This week we were at Smart City Expo World Congress (SCEWC) presenting the opportunities in public procurements for innovation at Parc Taulí.

leer más
Anais Medical and Nephrocloud have been presented to GEMAV, the 1st Spanish Congress on Vascular Access
1024 683 Xavier Gallego

Two innovative projects from Parc Taulí Hospital (ANAIS medical, and Nephrocloud) have been presented to the 1st Spanish congress on vascular access (GEMAV) held in Barcelona on 14-16 November 2019. Dr. Jose Ibeas, senior consultant in nephrology, vicepresident of the GEMAV, and member of the organizing committee, is leading both projects in collaboration with the…

leer más
Parc Taulí present Virtual Reality initiatives in Jornades R+D+I organised by TIC Salut Social
985 1024 Anna Ullastres

Last Wednesday 23th, we attended the Jornades R+D+I TIC Salut Social on Virtual Reality (VR) (take a look at the programme). Guillem Navarra, neuropsychologist researcher, and Lídia Martí, ICU nurse, were invited to present their projects using VR to improve both patient experience and recover: ENRIC: Early Neurocognitive Rehabilitation in Intensive Care. Using immersive VR…

leer más
CIBER researchers from Parc Taulí Jose Aquino and Leonardo Sarlabous
A new method to detect patient-ventilator interactions in critically ill patients receiving mechanical ventilation
1024 768 Esperanza Mancebo Gilabert

In order to study the interactions between critically ill patients receiving invasive mechanical ventilation and the machine, CIBER Researchers from the Critical Care Unit of Parc Tauli in collaboration with researchers from the Althaia Foundation, IRBLleida and BetterCare developed a new non-invasive approach based on non-linear methods in order to better characterize those in a group…

leer más
Global R&D Trends in 3D Printing
640 336 Edu Soler Alonso

3D printing (3DP) is a relatively new, rapidly expanding method of manufacturing that found numerous applications in healthcare. Today, it is rapidly expanding: almost every week new printers and printing materials offering novel possibilities as well as new exciting applications appear.

leer más
Open Market Consultation for the projects funded by the Innovative Public Procurement call in Health at Parc Taulí
600 600 Anna Ullastres

The Consorci Corporació Sanitaria Parc Taulí is preparing a public tender with the aim to incorporate innovation in the hospitals. In order to prepare these tenders, we launch an Open Market Consultation (OMC) to inform about key aspects of the proces.

leer más
The Safety HUG has been selected for the Collider program 2019-2020.
1024 576 Edu Soler Alonso

The Collider Program 2019 is an initiative promoted by The Mobile World Capital and the Generalitat of Catalunya to bring valuable research into the market. The last edition of  the programe contributed for the constitution of three new ‘start-ups’.

leer más
Two Innovative Projects from Parc Taulí Hospital Awarded by FIPSE
1024 768 Xavier Gallego

Taby Diagnostics and Safety Hug are two innovative projects that have recently been awarded by FIPSE (Fundación par la Innovación y la Prospectiva en Salud en España). The grant will give the projects the financial resources to cover those expenses associated to the evaluation of the market opportunity. Taby Diagnostics is developing an in vitro…

leer más
Parc Taulí is committed to invest in surgical planning through 3D printing
1024 768 Edu Soler Alonso

Since 2016, a research group of the Parc Taulí University Hospital has focused in applying 3D surgical planning to Orthopedic and Traumatology Surgery in order to improve complex orthopedic surgeries.The skills and the experience of the group has grown during these three years as well as the team’s composition and infrastructure.

leer más
Global R&D trends in Antimicrobial Resistance
960 528 Joaquim Campoy Rubio

Antimicrobial Resistance: A threat to global public health Antimicrobial resistance (AMR) is described as the ability of microorganisms such as bacteria, fungi, viruses and parasites to react against antimicrobial drugs, commonly through mutation, in order to render these ineffective –microbes are not inhibited and thereby they keep on multiplying and spreading.

leer más
  • 1
  • 2